NKGen Biotech, Inc.
NKGN
$0.1275
$0.00151.19%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -48.48M | -88.25M | -80.01M | -82.95M | -56.30M |
| Total Depreciation and Amortization | 1.28M | 1.25M | 1.23M | 1.20M | 1.21M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 20.87M | 60.66M | 53.44M | 57.58M | 33.45M |
| Change in Net Operating Assets | 5.46M | 4.80M | 4.29M | 2.23M | 1.16M |
| Cash from Operations | -20.87M | -21.54M | -21.07M | -21.95M | -20.48M |
| Capital Expenditure | -- | -- | -- | -- | 8.00K |
| Sale of Property, Plant, and Equipment | 35.00K | 35.00K | 35.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -50.00K | -33.00K | -35.00K | -48.00K | -43.00K |
| Cash from Investing | -15.00K | 2.00K | 0.00 | -48.00K | -35.00K |
| Total Debt Issued | 12.57M | 22.62M | 22.38M | 26.51M | 31.95M |
| Total Debt Repaid | -2.43M | -300.00K | -254.00K | -300.00K | 0.00 |
| Issuance of Common Stock | 350.00K | 1.67M | 1.68M | 1.68M | 1.68M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.59M | -3.59M | -3.20M | -5.73M | -4.17M |
| Cash from Financing | 12.08M | 20.39M | 20.60M | 22.16M | 29.46M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.80M | -1.14M | -464.00K | 159.00K | 8.95M |